Page 233 - Read Online
P. 233

Shibata                                                                              Living donor liver transplantation anastomotic stenosis interventional radiology balloon dilatation


               1.0                                              100
                                                                 90
               0.8                                               80
                                                                 70
             Patency rate  0.6                                 Patency rate (%)  60
                                                                 50
               0.4
                                                                 40
                                                                 30
               0.2                                               20
                                                                 10
               0.0                                                0

                    0                  50               100               150              200  0               50             100             150            200           250
                          Months after initial balloon dilatation       Months after initial percutaneous intervention
           Figure 5: Kaplan-Meier curve showing primary- and primary-assisted   Figure 7: Kaplan-Meier curve showing primary- and primary-assisted
           patency rates. Solid and dotted lines indicate primary patency and   patency rates. Solid and dotted lines indicate primary patency and
           primary-assisted patency, respectively. Vertical lines on both lines   primary-assisted patency, respectively. Vertical lines on both lines
           indicate censored observations. At 1, 3, 5, and 10 years after the first   indicate censored observations. The primary patency rates at 1, 3,
           balloon angioplasty the primary patency rates were 80%, 76%, 73%,   5, and 10 years after the initial drainage tube placement were 75%,
           and 67%, respectively, and the primary-assisted patency rates were   70%, 70%, and 68%, respectively. The primary-assisted patency
           100%, 100%, 100%, and 96% respectively             rates at 1, 3, 5, and 10 years after the initial drainage tube placement
                                                              were 94%, 92%, 88%, 88%, respectively

            A                   B                             placed, covering the Roux-Y jejunum and intrahepatic
                                                              bile ducts across the anastomotic stricture.

                                                              Serial exchanges for a larger 14-Fr or 16-Fr drainage
                                                              tube with or without balloon dilations were routinely
                                                              performed at 1- to 6-week intervals. At a follow-up
                                                              session, cholangiography was performed to evaluate
                                                              the persistence of stricture. If the stricture had widened
            C
                                                              and the laboratory data had resolved, the tube was
                                                              removed.

                                                              Results
                                                              In our reported study [22] , clinical success, tube
                                                              independent rate, and patency rate were evaluated.
                                                              Clinical  success  is  defined  as  resolution  or  marked
                                                              improvement of clinical symptoms including fever, and
                                                              improvement of laboratory findings, including the serum
                                                              levels of AST, ALT, total bilirubin, direct bilirubin, r-GTP,
           Figure 6: A 2-year-old boy who had undergone LDLT 20 months   and ALP. Tube independent rate is defined as the rate
           ago was suspected of having a biliary anastomotic stricture. (A)   at which the patient can undergo tube removal after
           PTC showing an anastomotic stricture; (B) fluoroscopic view during
           balloon dilatation. Balloon dilatation was performed at 10 atm for   symptoms are diminished and laboratory findings have
           3 min using a 6-mm-diameter balloon catheter; (C) fluoroscopic view   improved. Patency rate is estimated by the Kaplan-Meier
           shows an 8.5-Fr. internal-external drainage tube placed across the   analysis.  Primary  patency  is  defined  as  the  interval
           anastomotic stricture. After serial exchange with a larger diameter
           catheter (16-Fr), the drainage tube was removed. No recurrent   between placement of an internal drainage tube and
           stricture was noted for 117 months after the biliary interventions.   appearance of a recurrent biliary stricture necessitating
           LDLT: living donor liver transplantation; PTC: percutaneous   percutaneous biliary interventions. Primary-assisted
           transhepatic cholangiography
                                                              patency is defined as the interval between placement
                                                              of an internal drainage tube and when treatment with
           an  atmospheric  pressure  of  10  atm.  After  balloon   repeated percutaneous interventions is discontinued.
           dilatation, cholangiography was repeated to evaluate
           the  effectiveness.  Then,  an  8.5-Fr  internal-external   We performed IR for the 52 patients with anastomotic
           drainage  tube (Pig-tail  catheter,  Cook;  IN,  USA) was   biliary stenosis after LDLT, whose follow-up periods
                           Hepatoma Research ¦ Volume 3 ¦ October 25, 2017                                225
   228   229   230   231   232   233   234   235   236   237   238